| Symbol | CTGL |
|---|---|
| Name | CITRINE GLOBAL CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 3088900 Israel 5 Golden Beach |
| Telephone | (972) 9 855 1422 |
| Fax | — |
| — | |
| Website | https://www.citrine-global.com/ |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Somekh Chaikin KPMG Israel; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001498067 |
| Description | Citrine Global Corp. is a plant-based wellness & pharma solutions company with its business activity comprised of developing wellness and pharma solutions, focused on science backed plant-based products to improve quality of life and complementary solutions for balancing side effects caused by using medicines, treatments, or an unbalanced lifestyle. Our headquarters and senior management are based in Israel where we operate via our 100%-owned-subsidiary, Citrine Global Israel & 60%-owned-subsidiary, Cannovation Center. Our presence in Israel and our contacts with leading universities, companies, and governmental support powers us to access the latest technologies. We developed more than 100 wellness products & nutritional supplements under the Green Side by Side™ and GreenFeels™ brands and plan to market them worldwide in compliance with local regulations, focusing on the U.S. market, through building a global network of local teams and partnerships with distributors, retail and pharmacy chains, and M&As with distribution companies. We are building the Green Vision Center, a first-of-its-kind production and innovation center, providing in a single location everything required for production, innovation, and release-to-market of plant-based wellness & pharma products. Our mission is to leverage the power of plant-based solutions from nature and bring to market, on a global scale, innovative plant-based wellness & pharma solutions to improve peoples quality of life. Additional info from OTC: |
No news found.